- Enterprise / partnership.
- Not disclosed
- Not disclosed
- —
- 2012
- US
Atomwise AtomNet
by Atomwise · founded 2012 · US
CNN-based virtual screening of billions of compounds.
- Regulatory & Compliance0/22
No FDA clearance listed
- Clinical Integration0/26
No EHR integrations listed
- Evidence Strength0/27
No peer-reviewed coverage
- Vendor & Market13.8/21.6
market_relevance=70 (early-stage)
- Sentiment & Transparency3/15
1 pricing tier(s) but no $ amounts (contact-sales pattern)
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance0/12
No FDA clearance listed
- HIPAA / SOC2 / BAA0/10
No public HIPAA/SOC2/BAA attestation
- EHR integrations (count)0/14
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/8
None of the top-3 EHRs covered
- Bidirectional write-back0/4
No bidirectional write-back documented
- Peer-reviewed papers0/21
No peer-reviewed coverage
- RCT / meta-analysis / systematic review0/6
No RCT, meta-analysis, or systematic review
- Funding & adoption signal8/16
market_relevance=70 (early-stage)
- Years in market6/6
Founded 2012 (14 years)
- Clinician sentiment (Reddit)0/9
No clinician sentiment data available
- Pricing transparency3/6
1 pricing tier(s) but no $ amounts (contact-sales pattern)
Last computed May 26, 2026 · Rubric v1.0.0
CNN-based virtual screening of billions of compounds.
Free tier available.
We do not yet have enough independent sources for Atomwise AtomNet to publish a full editorial review. A complete review requires peer-reviewed coverage, clinician sentiment from public forums, or hands-on testing notes from our editorial team.
The vendor overview below reflects what we have verified from the vendor and from our category-level reporting. When additional sources surface, the review is regenerated automatically and dated. If you have direct hands-on experience and want to share it on the record, write to editorial@medaiverdict.com.
CNN virtual screening via partnerships.
What it costs
Free tier only; no paid plans publicly disclosed.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Plan | — | — | Enterprise / partnership. |
Source: vendor pricing page. Verified July 3, 2026.
Who builds it
Atomwise AtomNet (Atomwise) was founded in 2012 in US, putting it 14 years into market.
Other drug info
See the full drug info ranking
UpToDate Lexidrug
by Wolters Kluwer
Gold-standard drug reference + interaction screening (formerly Lexicomp).
Enterprise (institutional only).
Schrödinger
by Schrödinger Inc.
Physics-based molecular simulation + ML platform.
Enterprise software + co-development.Epocrates
by Epocrates (athenahealth/Bain)
Most-used clinician drug-reference app in the US.
Free + $16.99/mo Plus + $159/yr Essentials.
Recursion
by Recursion Pharmaceuticals
Phenomics + ML drug discovery (merged with Exscientia 2024).
Enterprise / partnership.
